Annals ofTransplants

Volume: 3 - Number: 18 - April 15, 2005

Outstanding

Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy

The promise of myocardial repair – towards a better understanding

Heart failure clinics and outpatient management: review of the evidence and call for quality assurance

Clinical applications of B-type natriuretic peptide (BNP) testing

Clinical Investigation

Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation

Sympathetic reinnervation, exercise performance and effects of ß-adrenergic blockade in cardiac transplant recipients

Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation

N-terminal pro-brain natriuretic peptide: A new gold standard in predicting mortality in patients with advanced heart failure

Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients — The IMPROVED multi-centre study

Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation

Cardiomyopathy in children with mitochondrial disease: Clinical course and cardiological findings

Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response

The pro-apoptotic serum activity is an independent mortality predictor of patients with heart failure

Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death

Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure

Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure

CURRENT OPINION

Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension

ESC GUIDELINES

Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology

ESC GUIDELINES:

Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology

PRECLINICAL RESEARCH

A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy

Myocardial infarction increases ACE2 expression in rat and humans

Regulary Articles

Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report

Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure

Statin effects beyond lipid lowering—are they clinically relevant?

Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy

Review

Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy

Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction

The promise of myocardial repair – towards a better understanding

Heart failure clinics and outpatient management: review of the evidence and call for quality assurance

Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology

Clinical applications of B-type natriuretic peptide (BNP) testing